ReviewLung cancer (Amsterdam, Netherlands)2019

Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC).

Ana C Z Gelatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.